🔹 In Tech news this week…Fujitsu is partnering with the Australian Securities Exchange (ASX) to develop a next-generation…
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is a new selective inhibitor of SOAT2.…
Sign in to your account